Allergy Therapeutics
AGY.L
#7052
Rank
โ‚น37.00 B
Marketcap
โ‚น7.76
Share price
1.47%
Change (1 day)
212.44%
Change (1 year)

Revenue for Allergy Therapeutics (AGY.L)

Revenue in 2024: โ‚น6.06 Billion

According to Allergy Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น6.06 Billion. In 2024 the company made a revenue of โ‚น6.06 Billion a decrease over the revenue in the year 2023 that were of โ‚น6.53 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Allergy Therapeutics from 2002 to 2024

Annual revenue

Year Revenue Change
2024โ‚น6.06 B-7.09%
2023โ‚น6.53 B-14.85%
2022โ‚น7.66 B-24.38%
2021โ‚น10.14 B21.26%
2020โ‚น8.36 B2.87%
2019โ‚น8.13 B3.66%
2018โ‚น7.84 B8.18%
2017โ‚น7.25 B27.75%
2016โ‚น5.67 B-3.95%
2015โ‚น5.90 B-4.84%
2014โ‚น6.20 B19.6%
2013โ‚น5.19 B-7.74%
2012โ‚น5.62 B-3.05%
2011โ‚น5.80 B9.69%
2010โ‚น5.29 B-2.05%
2009โ‚น5.40 B0.56%
2008โ‚น5.37 B19.97%
2007โ‚น4.47 B18.31%
2006โ‚น3.78 B18.08%
2005โ‚น3.20 B12.59%
2004โ‚น2.84 B14.69%
2003โ‚น2.48 B23.14%
2002โ‚น2.01 B